A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia-Reference-Cited by-同舟云学术

A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia

Published:2016-06-16 Issue:9 Volume:1 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Luskin Marlise R.,Gimotty Phyllis A.,Smith Catherine,Loren Alison W.,Figueroa Maria E.,Harrison Jenna,Sun Zhuoxin,Tallman Martin S.,Paietta Elisabeth M.,Litzow Mark R.,Melnick Ari M.,Levine Ross L.,Fernandez Hugo F.,Luger Selina M.,Carroll Martin,Master Stephen R.,Wertheim Gerald B.W.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference29 articles.

1. Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia

2. DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

3. Origins of aberrant DNA methylation in acute myeloid leukemia

4. Quantitative DNA methylation predicts survival in adult acute myeloid leukemia

5. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital PCR-based GRHL2 methylation testing in acute myeloid leukemia: diagnosis, prognosis and monitoring;Epigenomics;2024-02

2. Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors;Cancers;2023-07-06

3. Correlation between methylation level of the SLC19A1 promoter region and methotrexate metabolism in adult acute lymphoblastic leukemia;Pharmacogenomics;2023-04

4. Epigenetically programmed resistance to chemo- and immuno-therapies;Advances in Cancer Research;2023

5. Roadmap on plasticity and epigenetics in cancer;Physical Biology;2022-04-18